Viking Therapeutics
VKTX
VKTX
140 hedge funds and large institutions have $92.8M invested in Viking Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6.66% less ownership
Funds ownership: 46.27% → 39.61% (-6.7%)
44% less capital invested
Capital invested by funds: $166M → $92.8M (-$73.5M)
Holders
140
Holding in Top 10
–
Calls
$1.06M
Puts
$637K
Top Buyers
| 1 | +$3.89M | |
| 2 | +$2.55M | |
| 3 | +$2.17M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.05M |
| 5 |
SCM
Sio Capital Management
New York
|
+$1.02M |
Top Sellers
| 1 | -$21M | |
| 2 | -$8.31M | |
| 3 | -$1.7M | |
| 4 |
Rafferty Asset Management
New York
|
-$1.05M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$767K |